Multiple myeloma: Detection of free monoclonal light chains by modified immunofixation electrophoresis with antisera against free light chains

by Arfa, A., Bollag, R.J, Cotter, T., Savage, N.M, Singh, G., Wilhite, D.
Published 2021

Autologous Induced Pluripotent Stem Cell–Based Cell Therapies: Promise, Progress, and Challenges

by Aivio, S., Madrid, M., Saklayen, N., Sumen, C.
Published 2021

Pomalidomide, bortezomib, and dexamethasone at first relapse in lenalidomide-pretreated myeloma: A subanalysis of OPTIMISMM by clinical characteristics

by Anderson, L.D., Jr, Beksac, M., Corso, A., Dimopoulos, M., Dürig, J., Engelhardt, M., Galli, M., Grote, L., Jenner, M., Jiang, R., Kanate, A.S, Larocca, A., Liberati, A.M, Lindsay, J., Moreau, P., Oriol, A., Pavic, M., Peluso, T., Richardson, P.G, Robak, P., Rodriguez-Otero, P., Salomo, M., Schjesvold, F., Sonneveld, P., Vural, F., Weisel, K., White, D., Yagci, M.
Published 2022

Single-center experience using anakinra for steroid-refractory immune effector cell-Associated neurotoxicity syndrome (ICANS)

by Chen, Y.-B, Cook, D., Defilipp, Z., Dey, B., El-Jawahri, A.R, Frigault, M.J, Gallagher, K., Horick, N., Leick, M.B, Lindell, K., Maus, M.V, McAfee, S.L, O'Donnell, P., Spitzer, T., Trailor, M., Wehrli, M.
Published 2022